COVID-19 vaccines for patients with haematological conditions.

Sun, Clare; Pleyer, Christopher; Wiestner, Adrian

Sun, Clare; Pleyer, Christopher; Wiestner, Adrian.

Affiliation

Sun C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: clare.sun@nih.gov.
Pleyer C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Lancet Haematol ; 8(5): e312-e314, 2021 05.

Article in En | MEDLINE | ID: mdl-33811822

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/complications; COVID-19/prevention & control; Hematologic Diseases/complications; COVID-19/immunology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; Hematologic Diseases/immunology; Hematologic Neoplasms/complications; Hematologic Neoplasms/immunology; Humans; Immunogenicity, Vaccine; SARS-CoV-2/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Hematologic Diseases Limits: Humans Language: En Journal: Lancet Haematol Year: 2021 Document type: Article Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google